Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

NCT05219968 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Sinusitis
Chronic Rhinosinusitis (Diagnosis)

Interventions

DRUG: LYR-210
DRUG: Sham procedure control
OTHER: Background Therapy

Sponsor

Lyra Therapeutics